Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LAP3 | P28838 | 3/20 | 1.00 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.63 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.63 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.63 |
| ▸ | S1PR4 | O95977 | 4/20 | 0.63 |
| ▸ | FDPS | P14324 | 4/20 | 0.63 |
| ▸ | ANPEP | P15144 | 1/20 | 0.59 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.59 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.52 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.52 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9307335 | 1.00 | LAP3 (1.00) | LAP3S1PR2S1PR1S1PR3S1PR4 | |
| SCHEMBL745344 | 1.00 | LAP3 (1.00) | LAP3S1PR2S1PR1S1PR3S1PR4 | |
| SCHEMBL5690430 | 1.00 | LAP3 (1.00) | LAP3S1PR2S1PR1S1PR3S1PR4 | |
| SCHEMBL5691588 | 1.00 | LAP3 (1.00) | LAP3S1PR2S1PR1S1PR3S1PR4 | |
| SCHEMBL15876022 | 1.00 | LAP3 (1.00) | LAP3S1PR2S1PR1S1PR3S1PR4 | |
| SCHEMBL1060233 | 1.00 | LAP3 (1.00) | LAP3S1PR2S1PR1S1PR3S1PR4 | |
| SCHEMBL5691911 | 1.00 | LAP3 (1.00) | LAP3S1PR2S1PR1S1PR3S1PR4 | |
| Bromide SCHEMBL6049728 | 0.98 | LAP3 (0.96) | LAP3S1PR2S1PR1S1PR3S1PR4 | |
| Bromide SCHEMBL6049732 | 0.98 | LAP3 (0.96) | LAP3S1PR2S1PR1S1PR3S1PR4 | |
| SCHEMBL7814294 | 0.98 | LAP3 (1.00) | LAP3S1PR2S1PR1S1PR3S1PR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1017636-B1 | USE OF AMINO METHYL PHOSPHONIC ACIDS OR THEIR SALTS TO INHIBIT BACTERIA FROM ADERING TO A SUBMERGIBLE SURFACE AND TO CONTROL BIOFOULING | BUCKMAN LABOR INC (US) | 2006-04-26 | — | — | EP | claimed |
| EP-1017636-A1 | USE OF AMINO METHYL PHOSPHONIC ACIDS OR THEIR SALTS TO INHIBIT BACTERIA FROM ADERING TO A SUBMERGIBLE SURFACE AND TO CONTROL BIOFOULING | BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) | 2000-07-12 | — | — | EP | claimed |
| US-5888405-A | TO INHIBIT BACTERIA FROM ADHERING TO A SUBMERGIBLE METAL SURFACE WITHIN AN AQUEOUS SYSTEM | BUCKMAN LABORATORIES INTERNATIONAL INC. (US) | 1999-03-30 | — | — | US | claimed |
| WO-1999006325-A1 | METHODS AND COMPOSITIONS FOR CONTROLLING BIOFOULING USING AMINO METHYL PHOSPHONIC ACIDS | BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) | 1999-02-11 | — | — | WO | claimed |
| US-9969758-B2 | Antimicrobial compounds | BIOMERIEUX (FR) | 2018-05-15 | — | — | US | disclosed |
| US-20170158720-A1 | Antimicrobial Compounds | BIOMERIEUX (FR) | 2017-06-08 | — | — | US | disclosed |
| EP-2383264-B1 | EPOXY COMPOUND PRODUCTION METHOD | SHOWA DENKO KK (JP) | 2015-03-04 | — | — | EP | disclosed |
| US-8536352-B2 | Method of producing epoxy compounds | SHOWA DENKO K.K. (JP) | 2013-09-17 | — | — | US | disclosed |
| US-8466303-B2 | Process for production of epoxy compound | SHOWA DENKO K.K. (JP) | 2013-06-18 | — | — | US | disclosed |
| EP-2383264-A1 | EPOXY COMPOUND PRODUCTION METHOD | Showa Denko K.K. (JP) | 2011-11-02 | — | — | EP | disclosed |
| US-20110263882-A1 | METHOD OF PRODUCING EPOXY COMPOUNDS | SHOWA DENKO K.K. (JP) | 2011-10-27 | — | — | US | disclosed |
| US-20110009652-A1 | PROCESS FOR PRODUCTION OF EPOXY COMPOUND | SHOWA DENKO KK (JP) | 2011-01-13 | — | — | US | disclosed |
| EP-2261219-A1 | PROCESS FOR PRODUCTION OF EPOXY COMPOUND | Showa Denko K.K. (JP) | 2010-12-15 | — | — | EP | disclosed |
| US-20070111126-A1 | Epoxidized low-molecular-weight ethylene polymer, release agent for electrophotographic toner, and electrophotographic toner for developing electrostatic charge image | MITSUI CHEMICALS, INC. (JP) | 2007-05-17 | — | — | US | disclosed |
| EP-1707579-A1 | EPOXIDIZED LOW-MOLECULAR-WEIGHT ETHYLENE POLYMER, MOLD-RELEASING AGENT FOR ELECTROPHOTOGRAPHIC TONER, AND ELECTROPHOTOGRAPHIC TONER FOR DEVELOPING ELECTROSTATIC IMAGE | Mitsui Chemicals, Inc. (JP) | 2006-10-04 | — | — | EP | disclosed |
| EP-1017636-B1 | USE OF AMINO METHYL PHOSPHONIC ACIDS OR THEIR SALTS TO INHIBIT BACTERIA FROM ADERING TO A SUBMERGIBLE SURFACE AND TO CONTROL BIOFOULING | BUCKMAN LABOR INC (US) | 2006-04-26 | — | — | EP | disclosed |
| EP-1017636-A1 | USE OF AMINO METHYL PHOSPHONIC ACIDS OR THEIR SALTS TO INHIBIT BACTERIA FROM ADERING TO A SUBMERGIBLE SURFACE AND TO CONTROL BIOFOULING | BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) | 2000-07-12 | — | — | EP | disclosed |
| US-5888405-A | TO INHIBIT BACTERIA FROM ADHERING TO A SUBMERGIBLE METAL SURFACE WITHIN AN AQUEOUS SYSTEM | BUCKMAN LABORATORIES INTERNATIONAL INC. (US) | 1999-03-30 | — | — | US | disclosed |
| WO-1999006325-A1 | METHODS AND COMPOSITIONS FOR CONTROLLING BIOFOULING USING AMINO METHYL PHOSPHONIC ACIDS | BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) | 1999-02-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110263882-A1 | METHOD OF PRODUCING EPOXY COMPOUNDS | AOX1, NOX4, AOC2 | LAP3 4459/4885S1PR2 3685/4885S1PR1 3876/4885 |
| US-20170158720-A1 | Antimicrobial Compounds | NGLY1, MRPL21, VIP | LAP3 851/4885S1PR2 4016/4885S1PR1 2909/4885 |
| US-20110009652-A1 | PROCESS FOR PRODUCTION OF EPOXY COMPOUND | DUOX2, EPX, DUOX1 | LAP3 4575/4885S1PR2 2599/4885S1PR1 2971/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.